Biolegend, 135010, PE anti-mouse CD127 (IL-7Rα) Antibody, 200μg

CD127 is a 60-90 kD type I transmembrane glycoprotein also known as IL-7 receptor α chain or IL-7Rα. It forms a heterodimer with the common γ chain (γc or CD132) which is shared with the receptors for IL-2, IL-4, IL-9, IL-13, IL-15, and IL-21. CD127 is expressed on immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, and bone marrow stromal cells. CD127 has been reported to be an useful marker for identifying memory and effector T cells. The ligation of IL-7 with its receptor is important for stimulation of mature and immature T cells as well as immature B cells proliferation and development.
200μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: IL-7Ra-IgG1 fusion protein
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone A7R34 is able to completely block the binding of clone S18006K to IL-7Rα. It does not block SB/199.
Application References(PubMed link indicates BioLegend citation): Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125. Hashi H, et al. 2001. J. Immunol. 166:3702. Taylor R, et al. 2007. J. Immunol. 178:5659. Mazzon C, et al. 2011. Blood. 118:2733. PubMed Jin J, et al. 2011. J. Immunol. doi:10.4049/jimmunol.1001238. PubMed
Product Citations: Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed Fan NW, et al. 2023. FASEB J. 37:e22855. PubMed Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed Kuczynski EA, et al. 2022. EMBO Mol Med. 14:e15816. PubMed Campisi L, et al. 2022. Nature. 606:945. PubMed Lin YH 2023. Immunity. 56(1):207-223.e8. PubMed Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed Wang D, et al. 2018. Immunity. 48:659. PubMed Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed Wei H, et al. 2021. Malar J. 20:89. PubMed Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed Mann M, et al. 2018. Cell Rep. 25:2992. PubMed Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed Parriott G, et al. 2020. Immunology. 160:280. PubMed Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed Emgård J, et al. 2018. Immunity. 143:419. PubMed Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed Flommersfeld S, et al. 2021. Immunity. :. PubMed Prosser A, et al. 2021. Cell Reports. 35(7):109141. PubMed Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed de Lucía Finkel P, et al. 2021. Sci Rep. 11:12233. PubMed La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed Belyaev N, et al. 2010. Nat Immunol. 11:477. PubMed White C, et al. 2015. J Immunol. 194:697. PubMed Kruta M, et al. 2021. Cell Stem Cell. :. PubMed Chen H, et al. 2021. iScience. 24:103387. PubMed Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed Chang P, et al. 2012. J Immunol. 189: 701. PubMed Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed Chen C, et al. 2020. Cell Rep. 2136:30. PubMed Bajaña S, et al. 2022. iScience. 25:103732. PubMed Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed Sun Y, et al. 2020. J Immunol. 205:2649. PubMed Dhayade S, et al. 2020. Nutrients. 12:. PubMed Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
RRID: AB_1937252 (BioLegend Cat. No. 135009) AB_1937251 (BioLegend Cat. No. 135010)
Structure: Type I transmembrane glycoprotein, associate with CD132, 60-90 kD
Distribution: Immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, bone marrow stromal cells
Function: T cell and immature B cell proliferation and development
Ligand/Receptor: IL-7
Cell Type: B cells, T cells, Thymocytes
Biology Area: Immunology
Molecular Family: CD Molecules, Cytokine/Chemokine Receptors
Antigen References: 1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125. 2. Okuno Y, et al. 2001. P. Natl. Acad. Sci. USA 99:6246. 3. Pillai M, et al. 2004. Leukemia Lymphoma 45:2403.
Gene ID: 16197
UniProt: View information about CD127 on UniProt.org
Clone: A7R34
Regulatory Status: RUO
Other Names: IL-7 receptor α chain, IL-7Rα
Isotype: Rat IgG2a, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.